Acute Ischemic Stroke Diagnosis Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Acute Ischemic Stroke Diagnosis Market Report Segments the Industry Into Diagnostic Technology (Computed Tomography, Magnetic Resonance Imaging, and More), End User (Hospitals, Diagnostic Imaging Centers, and More), and Geography. The Market Sizes and Forecasts are Provided in Terms of Value (USD).

Acute Ischemic Stroke Diagnosis Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Acute Ischemic Stroke Diagnosis Market with other markets in Healthcare Industry

Acute Ischemic Stroke Diagnosis Market Analysis by Mordor Intelligence

The acute ischemic stroke diagnosis market reached a valuation of USD 2.36 billion in 2025 and is forecast to climb to USD 3.37 billion by 2030, advancing at a 7.38% CAGR. The acute ischemic stroke diagnosis market is expanding on the back of population aging, widening adoption of advanced imaging protocols, and artificial-intelligence triage systems that speed clinical decision-making. AI-enabled large-vessel-occlusion detection has narrowed interpretation gaps and raised diagnostic sensitivity, while mobile stroke units have cut treatment delays by 25–40 minutes in several U.S. and EU studies. Extended mechanical-thrombectomy time windows out to 24 hours are driving demand for perfusion imaging and automated ASPECTS scoring, and national quality initiatives in North America and Europe are linking reimbursement to guideline adherence. Challenges persist around scanner capital costs, radiologist shortages, and uneven rural access, yet vendors are countering these hurdles with subscription AI bundles, portable CT systems, and tele-stroke networks.

Key Report Takeaways

  • By diagnostic technology, computed tomography led with 38.14% of the acute ischemic stroke diagnosis market share in 2024, while carotid and transcranial ultrasound is projected to record the fastest 8.12% CAGR through 2030.
  • By end user, hospitals controlled 58.73% of the acute ischemic stroke diagnosis market size in 2024; diagnostic imaging centers are forecast to grow the quickest at 7.89% CAGR to 2030.
  • By geography, North America dominated with 43.15% revenue share in 2024, whereas Asia-Pacific is set to expand at the strongest 8.25% CAGR over the same period. 

Segment Analysis

By Diagnostic Technology: AI Integration Drives CT Dominance

Computed tomography represented 38.14% of 2024 revenue, cementing its role as the frontline modality within the acute ischemic stroke diagnosis market. Non-contrast CT expedites hemorrhage exclusion in under 3 minutes, and CT angiography offers vessel-occlusion localization in the same session. The acute ischemic stroke diagnosis market size for CT sequences in comprehensive centers is projected to expand at a 6.9% CAGR on account of bundled AI licenses that raise detection sensitivity and streamline workflow. Ultrasound, specifically carotid and transcranial Doppler, is forecast to notch the quickest 8.12% CAGR as mobile stroke units and low-resource hospitals demand portable, radiation-free tools.

Magnetic resonance imaging remains vital for penumbral mapping. Diffusion-weighted and arterial-spin-labeling sequences differentiate core infarct from salvageable tissue, steering therapy when CT is inconclusive. Blood-based biomarker panels such as GFAP-D-dimer, now achieving 93% specificity, could shift prehospital triage paradigms but remain in clinical trials. Digital-subtraction angiography is reserved for complex endovascular planning, while AI-only decision-support software is emerging as a separate revenue line within the acute ischemic stroke diagnosis market, spurring integrated platforms that fuse modality data into a single clinical dashboard.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By End User: Diagnostic Centers Challenge Hospital Dominance

Hospitals accounted for 58.73% of 2024 sales in the acute ischemic stroke diagnosis market, anchored by emergency departments capable of door-to-needle benchmarks. Yet outpatient diagnostic centers are growing at 7.89% CAGR as payers steer non-critical imaging to lower-cost sites and as these centers slash average door-to-scan times below 15 minutes. Tele-stroke connectivity allows subspecialists to read scans remotely, enabling community imaging hubs to serve rural catchment areas. The acute ischemic stroke diagnosis market size attributable to imaging centers could approach USD 1.2 billion by 2030 if current referral-pattern shifts persist.

Mobile stroke units sit at the intersection of hospital and outpatient care, bringing scanners to the curbside. Early outcome data from Houston and Berlin demonstrate functional independence gains in treated patients, stimulating new municipal procurement cycles. The “others” segment, which includes AI-as-a-service platforms and cloud-based interpretation networks, is small today but highly scalable, offering investors asset-light entry points into the acute ischemic stroke diagnosis industry.

Market Share
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

North America captured 43.15% revenue in 2024, reflecting mature stroke networks and rapid AI adoption. Over 1,700 U.S. hospitals deploy Viz.ai across 60,000 providers, illustrating ecosystem depth. Texas mobile stroke units achieved meaningful rural-patient benefit by shaving 40 minutes off treatment lag. Despite declining reimbursement for stroke procedures, capital budgets stay robust because value-based purchasing rewards outcome improvements, sustaining equipment refresh momentum throughout the acute ischemic stroke diagnosis market.

Asia-Pacific is set to post an 8.25% CAGR to 2030, the fastest worldwide, as aging rates accelerate and governments expand stroke-care infrastructure. China’s incidence rose from 0.76 million in 1990 to 2.77 million in 2021, driving mass procurement of perfusion-capable CT scanners. Japan’s national stroke registry now mandates multimodal imaging, while India confronts a younger patient profile, with the modal age band at 41–50 years. Tele-stroke pilots across Indonesia and the Philippines signal policy recognition that technology can offset specialist shortages and geography constraints.

Europe shows steady expansion underpinned by coordinated research, such as the €26.9 million UMBRELLA project that funds AI tools and cross-border data sharing. Siemens Healthineers partners with the World Stroke Organization to standardize imaging protocols, giving the acute ischemic stroke diagnosis market a boost in Central and Eastern Europe [2]Wolfgang Reith, “Portable CT in Mobile Stroke Units,” Siemens Healthineers, siemens-healthineers.com. Middle East & Africa and South America trail due to infrastructure and workforce deficits, yet Ethiopia’s public-health campaigns and Hungary’s mobile truck clinics prove that targeted interventions can lift diagnostic access even in low-resource settings [3]Zuo-Fen Zhang, “Ischemic Stroke Burden in China 1990–2021,” BMC Neurology, bmcneurol.biomedcentral.com.

Acute Ischemic Stroke Diagnosis Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

Industry structure is moderately consolidated. GE Healthcare, Siemens Healthineers, and Philips command multi-modality portfolios and global service networks, but their edge is narrowing as software-first rivals carve share. GE partnered with RadNet and Sutter Health to embed AI stroke triage across 300+ California facilities, illustrating hardware-software convergence. Siemens Healthineers pursues a dual track: proprietary AI and alliances with advocacy bodies to accelerate adoption in emerging regions. Philips leverages its IntelliSpace platform to integrate CT, MRI, and ultrasound data into a single neurological dashboard.

Disruptors RapidAI and Viz.ai exemplify software scale: RapidAI operates in 1,500+ hospitals across 50+ countries, showcasing 98% sensitivity in large-vessel-occlusion detection; Viz.ai’s 1,700-hospital footprint positions it as the leading neurovascular software network. Brainomix focuses on automated ASPECTS and e-Stroke decision support in Europe. Workforce shortages present an opening for cloud-based reading services that combine AI with outsourced radiologist panels, further fragmenting the competitive field. Mobile imaging specialists such as Penumbra and Vena Medical, armed with FDA Breakthrough Device status for intravascular scopes, target procedural niches adjacent to core diagnostic segments. The interplay between legacy OEMs and AI-native platforms is likely to spur mergers, equity investments, and exclusive-distribution pacts over the next five years.

Acute Ischemic Stroke Diagnosis Industry Leaders

  1. Fujifilm Holdings Corporation

  2. Samsung Electronics Co. Ltd

  3. Ge Healthcare

  4. Koninklijke Philips NV

  5. Siemens Healthcare

  6. *Disclaimer: Major Players sorted in no particular order
Acute Ischemic Stroke Diagnosis Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • March 2025: Perfuze received FDA 510(k) clearance for Zipline Access Catheters and closed €22 million follow-on funding.
  • March 2025: The U.S. FDA approved TNKase (tenecteplase) for adult acute ischemic stroke treatment.
  • February 2025: Vena Medical’s MicroAngioscope secured FDA Breakthrough Device designation.
  • October 2024: Prolong Pharmaceuticals’ PP-007 earned FDA Fast-Track designation for acute ischemic stroke therapy.

Table of Contents for Acute Ischemic Stroke Diagnosis Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing AIS incidence in 65-plus population
    • 4.2.2 Wider adoption of multimodal CT & MR imaging protocols
    • 4.2.3 Expanding endovascular-thrombectomy time-window boosts imaging demand
    • 4.2.4 Mobile stroke units creating new point-of-care imaging niches
    • 4.2.5 National stroke-care quality initiatives and reimbursement incentives
    • 4.2.6 AI-triage software bundled with scanners accelerating replacement cycles
  • 4.3 Market Restraints
    • 4.3.1 High capital & maintenance cost of advanced scanners
    • 4.3.2 Shortage of neuroradiologists in emerging markets
    • 4.3.3 Payer push-back on perfusion CT reimbursement codes
    • 4.3.4 Equity gaps in stroke imaging access (rural & minority populations)
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter’s Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Bargaining Power of Suppliers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Intensity of Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Diagnostic Technology
    • 5.1.1 Computed Tomography (NCCT, CTA, CTP)
    • 5.1.2 Magnetic Resonance Imaging (DWI, SWI, ASL)
    • 5.1.3 Carotid & Trans-cranial Ultrasound
    • 5.1.4 Cerebral Angiography (DSA)
    • 5.1.5 Blood-based Biomarker Tests (GFAP-D-dimer panels, etc.)
    • 5.1.6 AI-enabled Stroke Decision-Support Software
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Diagnostic Imaging Centers
    • 5.2.3 Others
  • 5.3 By Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 GE HealthCare
    • 6.3.2 Siemens Healthineers
    • 6.3.3 Canon Medical Systems
    • 6.3.4 Koninklijke Philips N.V.
    • 6.3.5 Fujifilm Holdings
    • 6.3.6 Nihon Kohden
    • 6.3.7 Stryker Neurovascular
    • 6.3.8 Medtronic Neurovascular
    • 6.3.9 Penumbra Inc.
    • 6.3.10 RapidAI
    • 6.3.11 Viz.ai
    • 6.3.12 MicroPort Scientific
    • 6.3.13 Esaote SpA
    • 6.3.14 Neusoft Medical
    • 6.3.15 iSchemaView
    • 6.3.16 NovaSignal
    • 6.3.17 Ceribell

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Acute Ischemic Stroke Diagnosis Market Report Scope

As per the scope of the report, stroke occurs when blood flow to a part of the brain is interrupted as a result of a broken or blocked blood vessel. An ischemic stroke occurs when a blood vessel carrying blood to the brain is blocked or restricted by severely narrowed arteries or blood clots. The acute ischemic diagnosis included equipment/services that are involved in the diagnosis of acute ischemic stroke. The acute ischemic stroke diagnosis market is segmented by diagnostics type (computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and other diagnostics) and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Diagnostic Technology Computed Tomography (NCCT, CTA, CTP)
Magnetic Resonance Imaging (DWI, SWI, ASL)
Carotid & Trans-cranial Ultrasound
Cerebral Angiography (DSA)
Blood-based Biomarker Tests (GFAP-D-dimer panels, etc.)
AI-enabled Stroke Decision-Support Software
By End User Hospitals
Diagnostic Imaging Centers
Others
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
By Diagnostic Technology
Computed Tomography (NCCT, CTA, CTP)
Magnetic Resonance Imaging (DWI, SWI, ASL)
Carotid & Trans-cranial Ultrasound
Cerebral Angiography (DSA)
Blood-based Biomarker Tests (GFAP-D-dimer panels, etc.)
AI-enabled Stroke Decision-Support Software
By End User
Hospitals
Diagnostic Imaging Centers
Others
By Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

How big is the Acute Ischemic Stroke Diagnosis Market?

The Acute Ischemic Stroke Diagnosis Market size is expected to reach USD 2.36 billion in 2025 and grow at a CAGR of 7.38% to reach USD 3.37 billion by 2030.

Which diagnostic modality generates the largest revenue?

Computed tomography leads with 38.14% of 2024 revenue, driven by universal hospital presence and fast scan times.

Who are the key players in Acute Ischemic Stroke Diagnosis Market?

Fujifilm Holdings Corporation, Samsung Electronics Co. Ltd, Ge Healthcare, Koninklijke Philips NV and Siemens Healthcare are the major companies operating in the Acute Ischemic Stroke Diagnosis Market.

Why is Asia-Pacific the fastest-growing region?

Rapid population aging, rising stroke incidence, and expanding imaging infrastructure propel Asia-Pacific to an 8.25% CAGR through 2030.

Which region has the biggest share in Acute Ischemic Stroke Diagnosis Market?

In 2025, the North America accounts for the largest market share in Acute Ischemic Stroke Diagnosis Market.

Access Report